Bioprocessing Application Notes & Case Studies
-
Flexible Cell Culture Media For High Titer Production Of AAV In HEK 293
2/4/2026
To maximize the results of viral titer and full capsids, it's necessary to undertake systematic process development and optimization of AAV production. The choice of cell culture medium is foundational.
-
Development Of A Non-Standard Protein Therapeutic
2/4/2026
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
Application Of A Dual Spiking Strategy In Viral Clearance Studies
2/3/2026
Explore how an alternative spiking strategy can streamline viral clearance studies, reduce material demands, and maintain compliance while addressing the challenges posed by MLV and MMV.
-
Fab Antibody Fragment Titer Improvement
2/2/2026
Learn how systematic screening of unique expression strains and plasmid combinations can overcome low protein yields, achieving active Fab titers over 4 g/L.
-
Advancing An Integrated Biopharma Workflow Strategy
1/30/2026
Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.
-
Enhancing Novel Developability Through Automated MS Analytics
1/29/2026
Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.
-
Transforming Development Through Mass Spectrometry Data Analysis
1/29/2026
Mass spectrometry is vital for understanding PTMs in modern biologics. Explore key challenges and how streamlined analysis can reveal deeper, more sensitive insights into biotherapeutic structure.
-
End-To-End Workflow Integration For Antibody Development
1/29/2026
Modern antibody discovery generates massive, fragmented datasets that slow collaboration and decision‑making. Examine how unified digital workflows streamline R&D and improve data quality.
-
Automating Mass Spectrometry Analysis To Accelerate Oligonucleotide Drug Development
1/29/2026
Oligonucleotide therapeutics demand precise and efficient analytical workflows. Explore how automated data processing offers a faster path to understanding metabolites and advancing development.
-
Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With Automation
1/29/2026
Growing oligonucleotide complexity is straining traditional analytical workflows. See how automated LC‑UV‑MS processing offers a scalable way to boost throughput and reduce manual effort.